Spatial Genomics and Transcriptomics Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET OVERVIEW

Spatial genomics and transcriptomics is a method for assigning cell types to their locations in histological sections, mostly using mRNA readouts. This approach can also be utilized to identify the subcellular localization of mRNA molecules in tumors and tissues, as well as their cellular heterogeneity. Furthermore, spatial genomics and transcriptomics provide information on immune cells and define the subcellular distribution of transcripts under diverse conditions. Because it allows for quantitative gene expression results as well as DNA and RNA visualisation mapping inside tissue components, spatial genomics has significant potential in disease control. In spatial transcriptomics, sequencing techniques have a major share due to wide availability of sequencing platforms that assist study RNA architecture in cells or tissue and use of advanced techniques within a laboratory setup to study biological organisms, which require professional experts such as technicians and researchers.

MARKET SCOPE

The "Global Spatial Genomics And Transcriptomics Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the spatial genomics and transcriptomics market with detailed market segmentation by technology, product and end user. The report provides key statistics on the market status of the leading spatial genomics and transcriptomics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

•   Based on technology the market is segmented as, spatial transcriptomics, and spatial genomics.
  
•   Based on product the market is segmented as, instruments, consumables, and software.
  
•   Based on end user the market is segmented as, translational research, academic institutes, diagnostic laboratories, and pharmaceutical and biotechnology companies.
  

MARKET DYNAMICS

Drivers:

•   Growing prevalence of diseases such as cancer and diabetes.
  
•   Increasing demand for biomarkers along with high adoption of in-situ sequencing techniques is also expected to spur the market growth.
  
•   Rising demand for robust cancer diagnostic solutions is also expected to create growth opportunities for the market.
  

Restraints:

•   Whereas, high cost of equipment, lack of clarity about transcriptomic research are likely to restrain market growth.
  

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The spatial genomics and transcriptomics market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the spatial genomics and transcriptomics market in these regions.

IMPACT OF COVID-19 ON SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS

The report covers key developments in the spatial genomics and transcriptomics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from spatial genomics and transcriptomics market are anticipated to lucrative growth opportunities in the future with the rising demand for spatial genomics and transcriptomics in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the spatial genomics and transcriptomics market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

•   10x Genomics
  
•   Dovetail Genomics
  
•   Illumina, Inc
  
•   S2 Genomics, Inc
  
•   NanoString
  
•   Seven Bridges Genomic
  
•   Advanced Cell Diagnostics, Inc
  
•   Akoya Biosciences, Inc
  
•   Horizon Discovery Group plc
  
•   Bio-Techne
  

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Spatial Genomics and Transcriptomics Report Scope